Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Here’s What Happened

Fresenius SE & Co. (OTCMKTS:FSNUYGet Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $12.10, but opened at $12.63. Fresenius SE & Co. shares last traded at $12.7068, with a volume of 1,645 shares.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, June 23rd. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy”.

Read Our Latest Analysis on Fresenius SE & Co.

Fresenius SE & Co. Stock Performance

The stock has a fifty day simple moving average of $11.39 and a two-hundred day simple moving average of $13.07. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. The stock has a market capitalization of $28.20 billion, a price-to-earnings ratio of 16.69 and a beta of 0.63.

Fresenius SE & Co. (OTCMKTS:FSNUYGet Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%. Analysts forecast that Fresenius SE & Co. will post 1.03 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.

Featured Stories

Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.